Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$343K Sell
7,000
-87,100
-93% -$4.37M ﹤0.01% 4638
2014
Q2
$5.31M Buy
94,100
+73,500
+357% +$3.75M ﹤0.01% 1905
2014
Q1
$1.1M Buy
20,600
+8,700
+73% +$540K ﹤0.01% 3395
2013
Q4
$603K Buy
11,900
+2,100
+21% +$91.4K ﹤0.01% 4116
2013
Q3
$374K Buy
9,800
+9,300
+1,860% +$275K ﹤0.01% 4477
2013
Q2
$11K Buy
+500
New +$10.9K ﹤0.01% 8533

Other funds holding INCY

UBS's INCY Position: Q3 2014 in Review

UBS increased its Incyte (INCY) stake by 11% in Q3 2014, buying an estimated $1.86M and bringing the position to 363,029 shares worth $17.8M. The position accounts for 0.01% of the portfolio, ranked #1033.

UBS first reported a position in INCY in Q2 2013 and has held it in 6 quarters since. The position peaked at $18.4M in Q2 2014. 220 funds tracked by Wall St. Rank hold INCY as of Q3 2014.

  • UBS held 363,029 shares of Incyte worth $17.8M as of Q3 2014.
  • UBS bought 37,054 Incyte shares in Q3 2014, an estimated $1.86M.
  • Incyte made up 0.01% of UBS's portfolio in Q3 2014, its #1033 holding.
  • UBS first reported a position in Incyte in Q2 2013 and has held it in 6 quarters since.
  • UBS's Incyte position peaked at $18.4M in Q2 2014.
  • 220 funds tracked by Wall St. Rank held Incyte as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.